相关实验视频

Updated: Jun 9, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

面对同步多重原发性肺癌:在挑战和机遇的交叉点上进行导航

Xue He¹, Zhihui Yang¹, Fang Wu²

¹Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, PR China.

Lung cancer (Amsterdam, Netherlands)

|October 26, 2024

概括

先进的成像检测更多的同步多重原发性肺癌 (sMPLC). 本综述探讨了这些复杂的肺癌治疗的挑战和"手术+X"模型.

科学领域:

在瘤学瘤学.
放射学放射学是一门学科.
基因组学就是基因组学.

背景情况:

增加同步多重原发性肺癌 (sMPLC) 的检测需要新的治疗策略.
sMPLC通常呈现为地面玻璃不透明或结,主要是在早期,非吸烟的女性,经常作为腺癌.
高的EGFR突变率和病变异质性构成重大诊断和治疗障碍.

研究的目的:

综合审查和分析最近关于sMPLC的临床,放射和基因组数据.
评估sMPLC"手术+X"治疗模式的疗效.
确定sMPLC诊断,治疗和研究中的挑战,缺口和潜在突破.

主要方法:

关于sMPLC最近的临床和放射学研究的审查.
对sMPLC相关的基因组分析数据的分析.
复杂的sMPLC场景的案例研究分析.

主要成果:

由于先进的CT扫描,sMPLC检测正在上升.
"手术+X"模型看起来有前途,但需要进一步调查.
EGFR突变和病变异质是影响治疗的关键因素.

结论:

多学科的方法对于管理sMPLC至关重要.
进一步的有针对性的研究对于推进sMPLC诊断和治疗至关重要.
了解sMPLC的复杂性可以显著影响整体肺癌研究.

关键词:

基因组特征的表征免疫治疗是一种免疫疗法.在SBRT和SBRT之间.外科手术手术手术同步的多重原发性肺癌.有针对性的治疗.

更多相关视频

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...